Telix Pharmaceuticals Limited (TLX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Telix Pharmaceuticals Lim...

    NASDAQ: TLX · Real-Time Price · USD
    10.17
    0.60 (6.27%)
    At close: Oct 01, 2025, 3:59 PM
    10.19
    0.20%
    After-hours: Oct 01, 2025, 07:26 PM EDT

    Telix Pharmaceuticals Income Statement

    Financials in AUD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 783.21M 502.55M 160.1M 7.6M
    Cost of Revenue
    		 273.53M 188.16M 130.76M 37.36M
    Gross Profit
    		 509.68M 314.39M 29.34M -29.77M
    Operating Income
    		 82.13M 51.89M -73.18M -81.25M
    Interest Income
    		 10.86M 235K 1K 163K
    Pretax Income
    		 56.06M 3.09M -98.62M -99.04M
    Net Income
    		 49.92M 5.21M -104.08M -80.51M
    Selling & General & Admin
    		 207.13M 134.16M 87.1M 40.81M
    Research & Development
    		 194.64M 128.84M 57.86M 34.13M
    Other Expenses
    		 54K n/a 3.09M 23.55M
    Operating Expenses
    		 427.55M 263.27M 102.52M 51.48M
    Interest Expense
    		 21.46M 13.56M 406K 189K
    Selling & Marketing Expenses
    		 85.47M 54.87M 37.97M 5.89M
    Cost & Expenses
    		 701.08M 451.03M 233.28M 88.84M
    Income Tax Expense
    		 6.14M -2.12M 5.46M -18.53M
    Shares Outstanding (Basic)
    		 331.23M 319.18M 310.64M 282.21M
    Shares Outstanding (Diluted)
    		 345.19M 323.71M 310.64M 282.21M
    EPS (Basic)
    		 0.15 0.02 -0.34 -0.29
    EPS (Diluted)
    		 0.14 0.02 -0.34 -0.29
    EBITDA
    		 92.55M 22.97M -92.84M -70.07M
    EBIT
    		 92.55M 16.22M -98.22M -75.25M
    Depreciation & Amortization
    		 n/a 6.74M 5.38M 5.17M

    Add to Watchlist